Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury

Transplant International

Volumn 25, Issue 8, 2012, Pages 897-908

  Bos, Eelke M ^a   Snijder, Pauline M ^a   Jekel, Henrike ^a   Weij, Michel ^a   Leemans, Jaklien C ^b   Van Dijk, Marcory C F ^a   Hillebrands, Jan Luuk ^a   Lisman, Ton ^a   Van Goor, Harry ^a   Leuvenink, Henri G D ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

apoptosis; heme oxygenase 1; hypometabolism; inflammation; necrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; HYDROGEN SULFIDE; INTERLEUKIN 6; MESSENGER RNA; PROTEIN BCL 2; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY TEMPERATURE; CONTROLLED STUDY; GRANULOCYTE; HEPATITIS; LIVER ISCHEMIA; LIVER NECROSIS; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; ASPARTATE AMINOTRANSFERASES; HYDROGEN SULFIDE; MALE; MICE; MICE, INBRED C57BL; REPERFUSION INJURY; SUPEROXIDES;

EID: 84863716143     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01514.x     Document Type: Article

References (44)

1. Fellström B, Aküyrek LM, Backman U, Larsson E, Melin J, Zezina L,. Postischemic reperfusion injury and allograft arteriosclerosis. Transplant Proc 1998; 30: 4278.
2. Howard TK, Klintmalm GB, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA,. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49: 103.
3. Kupiec-Weglinski JW, Busuttil RW,. Ischemia and reperfusion injury in liver transplantation. Transplant Proc 2005; 37: 1653.
4. Selzner M, Rüdiger HA, Sindram D, Madden J, Clavien PA,. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 2000; 32: 1280.
5. Selzner N, Rudiger H, Graf R, Clavien P-A,. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917.
6. Reiffenstein RJ, Hulbert WC, Roth SH,. Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol 1992; 32: 109.
7. Wang R,. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 2003; 5: 493.
8. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 2005; 42: 539.
9. 2S be the third endogenous gaseous transmitter? FASEB J 2002; 16: 1792.
10. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587.
11. (2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001; 20: 6008.
12. Zagli G, Patacchini R, Trevisani M, et al. Hydrogen sulfide inhibits human platelet aggregation. Eur J Pharmacol 2007; 559: 65.
13. Shintani T, Iwabuchi T, Soga T, et al. Cystathionine beta-synthase as a carbon monoxide-sensitive regulator of bile excretion. Hepatology 2009; 49: 141.
14. Papapetropoulos A, Pyriochou A, Altaany Z, et al. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 2009; 106: 21972.
15. Abe K, Kimura H,. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16: 1066.
16. Kimura H,. Hydrogen sulfide as a neuromodulator. Mol Neurobiol 2002; 26: 13.
17. Geng B, Chang L, Pan C, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 2004; 318: 756.
18. Whiteman M, Armstrong JS, Chu SH, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem 2004; 90: 765.
19. Whiteman M, Cheung NS, Zhu YZ, et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun 2004; 326: 794.
20. Szabõ C,. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6: 917.
21. 2S induces a suspended animation-like state in mice. Science 2005; 308: 518. (Pubitemid 40570576)
22. Elrod JW, Calvert J, Morrison J, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007; 104: 15560.
23. Khan AA, Schuler MM, Prior MG, et al. Effects of hydrogen sulfide exposure on lung mitochondrial respiratory chain enzymes in rats. Toxicol Appl Pharmacol 1990; 103: 482.
24. Porte RJ, Ploeg RJ, Hansen B, et al. Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group. Transpl Int 1998; 11 (Suppl 1): S164.
25. Leemans JC, Stokman G, Claessen N, et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894.
26. Morrison ML, Blackwood JE, Lockett SL, Iwata A, Winn RK, Roth M,. Surviving blood loss using hydrogen sulfide. J Trauma 2008; 65: 183.
27. Minamishima S, Bougaki M, Sips PY, et al. Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 2009; 120: 888.
28. 2 signaling. Circ Res 2009; 105: 365.
29. Liu H, Bai X-B, Shi S, Cao Y-X,. Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats. J Pharm Pharmacol 2009; 61: 207.
30. Fu Z, Liu X, Geng B, Fang L-P, Tang C-S,. Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sci 2008; 82: 1196.
31. Bos EM, Leuvenink HGD, Snijder PM, et al. Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 2009; 20: 1901.
32. Tripatara P, Patel NSA, Collino M, et al. Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 2008; 88: 1038.
33. Jha S, Calvert J, Duranski MR, Ramachandran A, Lefer D,. Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol 2008; 295: H801.
34. Kang K, Zhao M, Jiang H, Tan G, Pan S, Sun X,. Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Liver Transpl 2009; 15: 1306.
35. Zanardo RCO, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL,. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 2006; 20: 2118.
36. Ryter SW, Alam J, Choi AM,. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583.
37. Su H, van Dam GM, Buis CI, et al. Spatiotemporal expression of heme oxygenase-1 detected by in vivo bioluminescence after hepatic ischemia in HO-1/Luc mice. Liver Transpl 2006; 12: 1634.
38. Oh G-S, Pae H-O, Lee B-S, et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 2006; 41: 106.
39. Qingyou Z, Du J-B, Weijin Z, Hui Y, Tang C-S, Chunyu Z,. Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun 2004; 317: 30.
40. Blackstone E, Roth M,. Suspended animation-like state protects mice from lethal hypoxia. Shock 2007; 27: 370.
41. Goubern M, Andriamihaja M, Nübel T, Blachier F, Bouillaud F,. Sulfide, the first inorganic substrate for human cells. FASEB J 2007; 21: 1699.
42. 2S induced hypometabolism in mice is missing in sedated sheep. Resp Phys Neurobiol 2008; 160: 109.
43. Simon F, Giudici R, Duy CN, et al. Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia/reperfusion injury. Shock 2008; 30: 359.
44. Bos EM, Leuvenink HGD, van Goor H, Ploeg RJ,. Kidney grafts from brain dead donors: inferior quality or opportunity for improvement? Kidney Int 2007; 72: 797.